|
||
|
Venture capital firms and funds in Europe 128 Venture Capital Group 3i Venture Capital Accuitive Medical Acer Venture Capital Act Venture Capital Ltd Adelaide Venture Capital Email ADS Ventures Boston Advantages Of Venture Capital Advent Venture Capital Agio Capital Alabama Venture Capital Alaska Venture Capital All Stages Venture Capital American Venture Capital Analysis Venture Capital Analyze Venture Capital Angel Capital Appraisal Venture Capital Arch Venture Capital Argentina Venture Capital Arizona Venture Capital Arkansas Venture Capital Arrowpath Venture Capital Assess Venture Capital Assessment Venture Capital Atlas Venture Capital ATV Venture Capital Aurora Fund Australia Venture Capital Austria Venture Capital Automotive Venture Capital AZ Venture Capital VCgate More Venture Capital Terms and Topics
-
Altea Therapeutics Raised $33 in third round Venture Capital
December 30th, 2005 1 comment
Altea Therapeutics has been named a winner of a Georgia Biomedical Partnership (GBP) Deal of the Year award for a venture capital financing that raised almost $33 million, the largest venture capital deal in Georgia for 2005.
Altea Therapeutics, an emerging pharmaceutical company developing transdermal patches for the delivery of proteins and water-soluble drugs, raised $32.8 million in a third round of venture capital financing led by Aperture Venture Partners. The investor syndicate also included previous investors Domain, Venrock and vSpring Capital together with KBC, Quilvest, CX Ventures and Rockport Ventures.
Altea will use the additional resources to continue the clinical development of its lead products for pain management and diabetes control, and also to support the further development of processes for the fabrication of its commercial products. The company is conducting Phase 2 clinical trials in the U.S. with a daily hydromorphone patch for rapid management of moderate to severe pain and Phase 1 clinical trials in the U.S. with insulin patches that provide continuous delivery of basal levels of insulin for people with diabetes.
The Altea Therapeutics deal was part of increased venture capital funding of life sciences companies in Georgia in 2005. Three of the four largest venture capital deals, and one-half of the money raised in the top 10 deals, went to life sciences companies in 2005.
The Deal of the Year recognizes transactions, such as financings, collaborations, acquisitions and sales of businesses that represent significant successes by members of Georgia’s biosciences community.
Leave a reply
Latest Headlines:
Friday August 31, 2012
Zscaler Secures $38 Million Investment Round
Wednesday November 30, 2011
Health Care Solutions companies Infinity Pharmaceutics, NanoVobronix and Selventa raise funds.
Monday November 21, 2011
Panda Power opens $420 Million Fund for Solar and Natural Gas Projects
Thursday November 17, 2011
Better Place raises $200 Million for Electric Cars in the Series C of Funding
Wednesday November 16, 2011
Accel Partners raise $100 Million Big Data Fund to Invest in Hadoop, NoSQL and other Companies
Tuesday November 15, 2011
Skimlinks raises $4.5 Million to help Bloggers Increase their Gains
Monday November 14, 2011
Standing Cloud raises $3 Million to help New Cloud Providers grow Faster
Thursday November 10, 2011
Zillow acquires Diverse Solutions for $7.8 to help Real Estate Agents increase their Visibility
Hi there, You have performed an incredible job. I?ll certainly digg it and in my opinion recommend to my friends. I am confident they’ll be benefited from this website.